Amoxapine

Depression, Generalized Anxiety Disorder, Agitation + 4 more

Treatment

20 Active Studies for Amoxapine

What is Amoxapine

Amoxapine

The Generic name of this drug

Treatment Summary

Amoxapine is a type of antidepressant called a tricyclic antidepressant (TCA). It is related to the antipsychotic drug loxapine and works to increase serotonin and norepinephrine levels in the brain. This can help improve mood in people with depression. Amoxapine is used to treat depression, anxiety, and mixed symptoms of depression and anxiety. Common side effects of TCAs include sedation, low blood pressure, blurred vision, dry mouth, constipation, and urinary retention.

Amoxapine

is the brand name

image of different drug pills on a surface

Amoxapine Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Amoxapine

Amoxapine

1992

5

Effectiveness

How Amoxapine Affects Patients

Amoxapine is a type of antidepressant that is known to have a calming effect. It works differently than other antidepressants and has been shown to reduce the uptake of certain chemicals in the brain (nor-epinephirine and serotonin) and block the response of dopamine receptors to dopamine. It does not work as a monoamine oxidase inhibitor. Clinical studies have shown that amoxapine starts working faster than other antidepressants, such as amitriptyline and imipramine.

How Amoxapine works in the body

Amoxapine works by preventing the body from reabsorbing the chemical messengers norepinephrine and serotonin.

When to interrupt dosage

The suggested dosage of Amoxapine is subject to the determined illness, for instance Neurotic depression, Psychotic Depression and Agitation. The amount of dosage depends on the method of delivery (e.g. Oral or Tablet) featured in the table beneath.

Condition

Dosage

Administration

Agitation

, 50.0 mg, 25.0 mg, 100.0 mg, 150.0 mg

Tablet, , Oral, Tablet - Oral

Depression

, 50.0 mg, 25.0 mg, 100.0 mg, 150.0 mg

Tablet, , Oral, Tablet - Oral

Generalized Anxiety Disorder

, 50.0 mg, 25.0 mg, 100.0 mg, 150.0 mg

Tablet, , Oral, Tablet - Oral

Mental Depression

, 50.0 mg, 25.0 mg, 100.0 mg, 150.0 mg

Tablet, , Oral, Tablet - Oral

Psychotic Depression

, 50.0 mg, 25.0 mg, 100.0 mg, 150.0 mg

Tablet, , Oral, Tablet - Oral

Mental Depression

, 50.0 mg, 25.0 mg, 100.0 mg, 150.0 mg

Tablet, , Oral, Tablet - Oral

Neurotic depression

, 50.0 mg, 25.0 mg, 100.0 mg, 150.0 mg

Tablet, , Oral, Tablet - Oral

Warnings

Amoxapine Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Amoxapine.

Common Amoxapine Drug Interactions

Drug Name

Risk Level

Description

Acepromazine

Major

Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.

Aclidinium

Major

The risk or severity of adverse effects can be increased when Amoxapine is combined with Aclidinium.

Alfuzosin

Major

Amoxapine may increase the hypotensive activities of Alfuzosin.

Amisulpride

Major

Amoxapine may increase the antipsychotic activities of Amisulpride.

Aripiprazole

Major

Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.

Amoxapine Toxicity & Overdose Risk

Taking too much amoxapine can have serious side effects, such as seizures, coma, abnormal acid levels in the body, and kidney failure. Seizures are the most common symptom, and can lead to a medical emergency called status epilepticus. In rare cases, kidney failure can develop a couple days after overdosing.

image of a doctor in a lab doing drug, clinical research

Amoxapine Novel Uses: Which Conditions Have a Clinical Trial Featuring Amoxapine?

819 active clinical trials are investigating the potential of Amoxapine in treating Neurotic Depression, Agitation and Mental Despondency.

Condition

Clinical Trials

Trial Phases

Psychotic Depression

0 Actively Recruiting

Generalized Anxiety Disorder

181 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 4, Phase 1, Phase 3

Mental Depression

0 Actively Recruiting

Mental Depression

0 Actively Recruiting

Neurotic depression

0 Actively Recruiting

Depression

305 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4, Phase 3

Agitation

3 Actively Recruiting

Phase 2, Phase 3, Not Applicable

Amoxapine Reviews: What are patients saying about Amoxapine?

5

Patient Review

9/13/2020

Amoxapine for Depression

This drug was more effective than similar treatments I've tried in the past. At first, I experienced periods of involuntary yawning, but I quickly got used to it. My concentration while on this medication was amazing.

5

Patient Review

12/8/2008

Amoxapine for Depression

5

Patient Review

8/3/2011

Amoxapine for Depression

Amoxapine has been a complete game-changer for me since I started taking it in 1981.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about amoxapine

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the brand name for amoxapine?

"Amoxapine is a tricyclic antidepressant that is used to treat symptoms associated with depression, anxiety, or agitation."

Answered by AI

What is amoxapine used to treat?

"This medicine is used to treat the symptoms of depression by increasing levels of certain chemicals in the brain. This medicine is a tricyclic antidepressant (TCA) and is available only with a doctor's prescription."

Answered by AI

Is amoxapine an antipsychotic?

"The drug Amoxapine is marketed as an antidepressant, though it has similar in-vitro profiles, receptor occupancies, and preclinical effects to atypical antipsychotics. Amoxapine has shown to be effective as an atypical antipsychotic in open trials."

Answered by AI

What are the side effects of amoxapine?

"popular antidepressants can cause a number of

side effects, including nausea, drowsiness, weakness or tiredness, nightmares, dry mouth, skin more sensitive to sunlight than usual, changes in appetite or weight, and constipation."

Answered by AI

Clinical Trials for Amoxapine

Have you considered Amoxapine clinical trials?

We made a collection of clinical trials featuring Amoxapine, we think they might fit your search criteria.
Go to Trials
Image of Western Psychiatric Hospital/University of Pittsburgh in Pittsburgh, United States.

Sleep and Circadian Interventions for Suicide

18 - 25
All Sexes
Pittsburgh, PA

The purpose of this study is to examine the extent to which delivering sleep and circadian focused interventions in addition to evidenced based psychiatric care for depression and suicide risk may contribute to decreasing suicide risk among high risk young adults. Investigators will evaluate three interventions targeting sleep in acutely suicidal college students enrolled in intensive outpatient treatment. Participants will be randomly assigned to one of three intervention groups: 1. Triple Chronotherapy (TCT)+ Transdiagnostic Sleep and Circadian Intervention (TSC) 2. Transdiagnostic Sleep and Circadian Intervention (TSC) 3. Sleep Feedback (SF) Participants will be followed for 6 months with primary outcome domains of suicidal thoughts and behaviors and depression evaluated by blinded clinicians at short (Days 1-4 of intervention), medium (2 months) and long (6 month) term intervals.

Waitlist Available
Has No Placebo

Western Psychiatric Hospital/University of Pittsburgh

Tina Goldstein, PhD

Image of University of South Florida in Tampa, United States.

WeACT Program for Caregivers of People With Dementia

18+
All Sexes
Tampa, FL

The goal of this clinical trial is to learn whether WeACT, a self-paced, web-based program, is feasible and helpful for adult family caregivers of a relative living with dementia. WeACT is based on acceptance and commitment therapy (ACT), which teaches skills to handle difficult thoughts and feelings and take steps toward what matters most. The main questions this study aims to answer are: * Can caregivers complete WeACT as planned? * Do caregivers show improvements in mental health and coping after using WeACT? * What are caregivers' experiences with the program, and what suggestions do they have to improve it? Participants will: * Complete six self-paced weekly online modules and use the daily practice section during the program. * Complete online questionnaires before starting and after completing the program. * Take part in one online interview about their experience.

Waitlist Available
Has No Placebo

University of South Florida

Areum Han

Image of Fred Hutch/University of Washington Cancer Consortium in Seattle, United States.

Psilocybin Therapy for Anxiety and Depression in Cancer

18 - 85
All Sexes
Seattle, WA

This phase II trial tests the safety, side effects and how well group retreat psilocybin therapy works for the treatment of anxiety and depression in patients with solid tumors that have spread from where they first started (primary site) to other places in the body (metastatic) or with hematologic cancers for which no treatment is currently available (incurable). For patients with metastatic, incurable cancer, unrelieved anxiety and existential distress can cause profound suffering. Psilocybin therapy can relieve anxiety and existential distress by disrupting patterns of thinking that contribute to anxiety and depression. Psilocybin is a substance being studied in the treatment of anxiety or depression in patients with cancer. In this study, a pharmaceutical grade of psilocybin will be used that has been approved by the FDA for research, provided by Filament Health. Psilocybin acts on the brain by resetting the brain's activity and increasing connections between brain regions, particularly those involved in mood regulation and self-perception. In this study psilocybin is combined with structured discussions and reflections that enable patients to have new insights about their situation. In a prior study, group retreat psilocybin therapy was proven to be safe and this study tests a refined dosing regimen for symptoms of anxiety and depression in patients with metastatic solid tumors or incurable hematologic malignancies.

Phase 2
Waitlist Available

Fred Hutch/University of Washington Cancer Consortium

Anthony Back, MD

Image of Wahwala Iyohlogya/Peaceful Means in Pine Ridge, United States.

Lakota Family Acceptance Program for Depression and Anxiety

Any Age
All Sexes
Pine Ridge, SD

The goal of this open pilot trial (OPT) is to develop a Lakota-adapted Family Acceptance Project (LFAP) for Indigenous 2SLGBTQ+ youth and their caregivers. The OPT is specifically focused on acceptability, feasibility, and safety of programming and research protocols. The investigators will also examine pre- to post- changes on outcomes for the sole purposes of making sure scores on measures are changing in the hypothesized direction (e.g., depression scores are going from moderate to minimal as opposed to no change or depression scores increasing). Once enrolled in the study, participants complete a baseline survey. Then participants will engage in LFAP which is an 8-session group intervention; sessions will be scheduled once a week for eight weeks (at 2 hours per session). Participants will complete survey instruments before and immediately after the program sessions, in addition to post-program surveys and an exit interview.

Recruiting
Has No Placebo

Wahwala Iyohlogya/Peaceful Means (+1 Sites)

Katie Edwards, PhD

Have you considered Amoxapine clinical trials?

We made a collection of clinical trials featuring Amoxapine, we think they might fit your search criteria.
Go to Trials
Image of Seaway Valley Community Health Centre (Cardiac Rehab Program) in Cornwall, Canada.

FRAME for Heart Failure

18+
All Sexes
Cornwall, Canada

Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives. Despite this interconnection, the integration of mental health awareness and support into cardiac care remains limited. To address this gap, the FRAME (Foundation, Recognition, Awareness, Management, Engagement) intervention was co-designed by researchers, healthcare providers, health system decisionmakers, and patient partners. This pilot study evaluates the feasibility of implementing the FRAME intervention in pilot clinical sites within two health regions in Ontario, Canada, including team-based family medicine clinics, cardiac rehabilitation/specialist clinics, and emergency departments. Utilizing a pretest-posttest hybrid 1 model intervention design, this study evaluates process indicators and patient-focused outcomes through surveys and semi-structured qualitative interviews. Findings from this study will inform a future large scale cohort study and scalable integration of the FRAME tool into existing cardiac care pathways to enhance mental health awareness and support among heart failure patients.

Recruiting
Has No Placebo

Seaway Valley Community Health Centre (Cardiac Rehab Program) (+8 Sites)

Image of Fort Bend ISD in Sugar Land, United States.

Wellbeing Interventions for Anxiety

10 - 20
All Sexes
Sugar Land, TX

The goal of this clinical trial is to learn if psychology and music based interventions can impact anxiety and overall wellbeing in adolescents enrolled in choral music classes. The main questions it aims to answer are: Do specific psychology and music based breathing interventions impact anxiety and overall wellbeing in adolescents? Do specific psychology and music based performance anxiety reduction interventions impact anxiety and overall wellbeing in adolescents? Do specific psychology and music based emotion regulation interventions impact anxiety and overall wellbeing in adolescents? Researchers will compare results of pre-test data, post-test data, qualitative interviews, and surveys of adult choral directors to see if there is a measurable impact on adolescent anxiety and overall wellbeing. Participants will: * Use box breathing during choral music warm-ups to connect choral breathing to breathing for anxiety reduction * Use "magnify" technique to compare cognitive distortions regarding an upcoming performance that may cause anxiety to the most likely realistic outcome * Use emotion regulation through song lyrics technique to connect lyrics of choral music repertoire to participants experienced emotions

Waitlist Available
Has No Placebo

Fort Bend ISD

Jane Kuehne, PhD

Have you considered Amoxapine clinical trials?

We made a collection of clinical trials featuring Amoxapine, we think they might fit your search criteria.
Go to Trials